A Study on Aruvadha chooranam in the management of Kaleeral noi(Non- Alcoholic fatty liver disease)

An open Non-Randomised Single Arm Single Centric Clinical Trial to evaluate the effectiveness of Aruvadha Chooranam in the management of Kaleeral Noi(Non- Alcoholic Fatty Liver Disease) among outpatients attending Ayothidoss Pandithar Hospital National Institute Of Siddha - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056413

Enrollment

Registered

2023-08-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Aruvadha chooranam: 2g bds with hotwater for 90 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with any of the symptoms of NAFLD/YAGUDHAM such as pain or discomfort in the right upper quadrant/epigastric region of the abdomen, nausea, vomting, indigestion, anorexia, early satiety, fatigue, bloating and distension. 2.Patients with USG findings suggestive of fatty liver grades 1,2,3 showing fatty infiltration of the liver

Exclusion criteria

Exclusion criteria: 1.Patients who are known to consume alcohol 2.Patients with chronic kidney disease, cardiovascular diseases 3.Patients with known liver diseases such as viral hepatitis, autoimmune disorders, biliary disorders, liver abscess, liver cirrhosis and malignancy 4.Pregnancy associated with liver disease

Design outcomes

Primary

Measure	Time frame
Improvement in grades of fatty liver in USG abdomen scan will be assessed before & after treatmentTimepoint: 18 months	—

Secondary

Measure	Time frame
1 Reduction in values of lipid profile, & LFT will be assessed before & after treatment 2 Anthropometric changes such as waist circumference & BMI wibb be assessed before and after treatmentTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr T Sophiya

National Institute of Siddha

drlakshmiramaswamy@gmail.com9444466880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026